Medical Use
Qelbree (Viloxazine 100 mg, 150 mg, and 200 mg) is a selective norepinephrine reuptake inhibitor commonly prescribed for treating Attention Deficit Hyperactivity Disorder (ADHD) in both adults and children aged 6 years and older.
Recommended Dosage:
- -Administration: Take Qelbree orally, with or without food. Do not chew, cut, or crush the capsules. Swallow them whole, or open the capsules and sprinkle the contents over a tablespoon or teaspoon of pudding or applesauce. Consume the mixture entirely within 15 minutes if using pudding, or within a couple of hours if using applesauce. Do not store the mixture for future use.
Pediatric Patients:
- -Ages 6-11: Start with 100 mg orally once daily. The dosage can be increased by 100 mg each week, up to a maximum of 400 mg daily, based on response and tolerability.
- -Ages 12-17: Start with 200 mg orally once daily. After one week, the dosage can be increased by 200 mg, up to a maximum of 400 mg daily, based on response and tolerability.
Adult Patients:
- -Starting Dosage: Begin with 200 mg orally once daily. The dosage can be increased by 200 mg each week, up to a maximum of 600 mg daily, based on response and tolerability.
- -Long-term Use: ADHD treatment may be needed for extended periods. Regularly reevaluate the long-term use of Qelbree and adjust the dosage as necessary.
Warning & Precautions
Evaluate heart rate and blood pressure before starting treatment with Qelbree (Viloxazine) 100 mg, 150 mg, or 200 mg capsules, after any dosage increases, and periodically throughout the therapy.
Before initiating treatment with Viloxazine capsules (100 mg, 150 mg, 200 mg), screen patients for a personal or family history of bipolar disorder, suicide, and depression.
Suicidal Thoughts/Behaviors: Higher rates of suicidal thoughts and behaviors have been reported in both pediatric and adult patients with ADHD treated with Viloxazine. Closely monitor patients for clinical worsening and the emergence of suicidal thoughts or behaviors.
Cardiovascular Effects: Viloxazine can cause an increase in heart rate and diastolic blood pressure. Evaluate heart rate and blood pressure before starting treatment, following dosage increases, and periodically during therapy.
Bipolar Disorder Risk: Noradrenergic medications like Qelbree may induce manic or mixed episodes in patients with bipolar disorder. Screen patients for bipolar disorder risk before starting treatment.
Fatigue and Somnolence: Qelbree can cause fatigue and drowsiness. Patients should avoid activities requiring mental alertness, such as driving or operating machinery, until they know how the medication affects them.
Pregnancy: Viloxazine may cause harm if used during pregnancy. Discontinue treatment if pregnancy is detected unless the benefits outweigh the potential risks to the mother.
Documentation Availability
Documents required to import QELBREE to India?
QELBREE (viloxazine) capsules can be imported by patients or treating physicians on behalf of patients. The following documentation is required to import the product:
- (i)2 ID proofs along with PAN card details along with attested scanned copies
- (ii)Valid doctor prescription scanned copy
- (iii)Doctor’s MCI number
- (iv)Doctor’s mobile number
- (v)Patients diagnostic reports
How is the order confirmed?
The order will be confirmed only after the receipt of:
- (i)The above-mentioned documents and drug availability.
- (ii)Import permit if applicable.
Sourcing & Delivery
The Rx4U team has extensive experience in sourcing QELBREE from around the world, ensuring global access to the best available treatments for our customers. We are dedicated to promptly dispensing any valid prescription. All prescriptions are verified and dispatched directly to the patient’s address. Our patients are our top priority, and we strive to improve their lives through our services.
FAQ
What is the Generic Name for the trade name drug Qelbree®?
Viloxazine is a Generic Name for the trade name drug Qelbree®.
What is the Manufacturer Name of Qelbree®?
Qelbree® is manufactured by Supernus Pharmaceuticals, Inc.
Is Qelbree® approved by the FDA?
Yes, Qelbree® is approved by the FDA. Date of first/initial approval: April 2, 2021.
What is the dosage and form of Qelbree® supplied?
Qelbree® is supplied as Capsules: 100 mg, 150 mg and 200 mg for oral administration.
Where can I get Qelbree® capsule at the best price in India?
To get the best Qelbree® capsule price in India, kindly reach to Rx4u team.
What are the most common side effects of Qelbree®?
The most common side effects of Qelbree in pediatric patients 6 to 17 years of age are somnolence, decreased appetite, fatigue, nausea, vomiting, insomnia, and irritability,
The most common side effects of Qelbree in Adult patients are nausea, fatigue, decreased appetite, somnolence, dry mouth, insomnia, headache, and constipation.
How much does Qelbree® cost in India?
The Qelbree® cost in India can vary. To procure this medicine, kindly place the order at https://rx4u.in/
What are the storage conditions of Qelbree®?
Store Qelbree at temperature 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F).
Is it safe to buy Qelbree® capsules online from India?
Yes, you can buy Qelbree® capsules online at the best at https://rx4u.in/
*Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and Rx4U does not lay any claim on them we only provide Information.
